Ju Kon Kim
Corporate Officer/Principal bei Myongji University
Profil
Ju Kon Kim is currently the Head of the Biology Department at Myongji University, a position he has held since 1995.
Prior to this, he worked as a Research Scientist at Seoul National University from 1979 to 1995.
He also served as the Chief Scientific Officer at GreenGene BioTech, Inc. Additionally, he earned a doctorate degree from Cornell University in 1990, an undergraduate degree from Seoul National University in 1977, and a graduate degree from Korea Advanced Institute of Science & Technology in 1979.
Aktive Positionen von Ju Kon Kim
Unternehmen | Position | Beginn |
---|---|---|
Myongji University | Corporate Officer/Principal | 29.04.2011 |
Ehemalige bekannte Positionen von Ju Kon Kim
Unternehmen | Position | Ende |
---|---|---|
Seoul National University | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1995 |
GreenGene BioTech, Inc.
GreenGene BioTech, Inc. BiotechnologyHealth Technology GreenGene BioTech, Inc. is a holding company, which engages in rice plant gene development and commercialization. Its products include protein binding and expression microarray. It also provides primer walking, flanking deoxyribonucleic acid, and whole genome services. The company was founded in March 2000 and is headquartered in Yongin-si, South Korea. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Ju Kon Kim
Seoul National University | Undergraduate Degree |
Korea Advanced Institute of Science & Technology | Graduate Degree |
Cornell University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
GreenGene BioTech, Inc.
GreenGene BioTech, Inc. BiotechnologyHealth Technology GreenGene BioTech, Inc. is a holding company, which engages in rice plant gene development and commercialization. Its products include protein binding and expression microarray. It also provides primer walking, flanking deoxyribonucleic acid, and whole genome services. The company was founded in March 2000 and is headquartered in Yongin-si, South Korea. | Health Technology |